Repligen Corporation has grown revenue 3.3% a year over three years and 9.1% a year over five, with earnings per share compounding at −31%. Revenue growth, 3-year annual rate: +3.3% (Medical Instruments & Supplies median +10%). Revenue growth, 5-year rate: +9.1%, growth has slowed since the five-year average. Earnings per share, 3-year rate: −31%, earnings lagged revenue: the growth is costing something. Years of annual history on file: 16, FY2009 to FY2025, as filed.

RGENRepligen Corporation

HealthcareUSD

$180.23

$102.8752 weeks$181.76

Is it growing?

Is RGEN growing?

Repligen Corporation has grown revenue 3.3% a year over three years and 9.1% a year over five, with earnings per share compounding at −31%.

+3.3%

Revenue growth, 3-year annual rate · Medical Instruments & Supplies median +10% · growing slowly · compounded from trailing twelve-month revenue

Revenue growth, 5-year rate: +9.1%
Revenue growth, 5-year rate · +3.3% over three · growth has slowed since the five-year average
Earnings per share, 3-year rate: −31%
Earnings per share, 3-year rate · revenue +3.3% · earnings lagged revenue: the growth is costing something
Years of annual history on file: 16
Years of annual history on file · FY2009 to FY2025, as filed